Previous Statements by JAZZ
» Jazz Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript
» Jazz Pharmaceuticals Inc. Q2 2008 Earnings Call Transcript
» Jazz Pharmaceuticals, Inc. Q1 2008 Earnings Call Transcript
David Hung will become Axovant's CEO after completing the $14 billion sale of Medivation to Pfizer.
ChemoCentryx, Jazz Pharmaceuticals, Ionis Pharmaceuticals and Zogenix were among the biotech stock movers in premarket trading Friday.
Jim Cramer looks for domestic stocks he thinks will benefit from lower taxes and deregulation in the Trump era.